CCHR chapters around the continent continue to collect expert evidence and documentation that both refutes utterly psychiatry’s claims as to the efficacy of their so-called “miracle drugs” and exposes the havoc and destruction those substances wreak upon society.

Dr David Healy, research psychopharmacologist (University of Wales), said that Seroxat, an antidepressant, increases the chance of user suicide by 130 times. Dr Peter Mansfield (University of Adelaide, Australia) found that a person is 38 times more likely to commit suicide while taking certain psychiatric drugs than if he or she did not.

In the face of these and other tragic statistics, the UK government in 2003 banned the use of several Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants on under 18-year-olds, citing suicidal tendencies caused by the drug. American, Canadian and Japanese drug approval agencies have subsequently followed suit, issuing warnings against the prescribing of Seroxat to children.

In December 2004, the European Agency for the Evaluation of Medicinal Products issued a ruling that the SSRI drugs are not authorised Europe-wide for the treatment of so-called “depression” and “anxiety disorders” in children or adolescents, as these drugs can lead to suicide.

In America, a U.S. congressional subcommittee held hearings in September 2004 into SSRI antidepressants and heard testimony from 73 people, 48 of whom were parents of children who had died—or whose lives had been destroyed—due to the effects of psychiatric drugs. As a result, the U.S. Food and Drug Administration (FDA) ordered that a “black box” warning label be prominently placed on all SSRI antidepressant drugs to tell consumers that such drugs can cause suicidal behaviour in children.